Analysis of clinical efficacy of blue light combined supportive therapy in pathological jaundice of full-term newborns
蓝光联合支持治疗方案应用于足月新生儿病理性黄疸的临床疗效探析

摘要

探析蓝光联合支持治疗方案应用于足月新生儿病理性黄疸的临床疗效。方法 以2023年01月-2024年02月为研究时间，择取期间内在本院治疗的足月新生儿病理性黄疸患儿中的100例为研究对象，依照入组顺序随机分组，对照组（50例）采用蓝光照射治疗，观察组（50例）采用蓝光联合支持治疗方案。结果 观察组患儿血清胆红素指标、炎症因子水平明显优于对照组，血清胆红素恢复正常时间、住院时间更短，临床治疗总有效率更高，P＜0.05，具有统计学意义。结论 蓝光联合支持治疗方案应用于新生儿病理性黄疸的临床疗效显著，有效改善患儿相关生理指标，促进患儿病情更快康复，建议推广应用。

Abstract

Objective To explore the clinical efficacy of blue light combined with supportive therapy in the treatment of pathological jaundice in full-term newborns.
Methods From January 2023 to February 2024, 100 full-term newborns with pathological jaundice treated in our hospital during this period were selected as the research subjects. They were randomly divided into two groups according to the order of enrollment: the control group (50 cases) received blue light irradiation treatment, and the observation group (50 cases) received blue light combined with supportive treatment.
Results The serum bilirubin index and inflammatory factor levels in the observation group were significantly better than those in the control group. The recovery time of serum bilirubin was shorter, the hospitalization time was shorter, and the overall clinical treatment effective rate was higher, P＜0.05, Has statistical significance.
Conclusion   The clinical efficacy of blue light combined with supportive therapy for neonatal pathological jaundice is significant, effectively improving relevant physiological indicators of the child and promoting faster recovery. It is recommended to promote its application.